Home Cell Cycle CDK4/6

CDK4/6

Other Cell Cycle Related Inhibitors

CDK ROCK Wee1 Aurora Kinase Chk PLK APC MPS1 Rho Myc
Cat.No. Product Name Information Product Use Citations Product Validations
E6647New Bireociclib (XZP-3287,CDK4/6-IN-2) CDK4/6-IN-2 is a CDK4 and CDK6 inhibitor obtained from patent US20180000819A1 (Compound 1). It exhibits IC50 values of 2.7 nM for CDK4 and 16 nM for CDK6.
E6678New PRT3645 PRT3645 is a brain-penetrant CDK4/6 inhibitor that exhibits single-digit nanomolar biochemical potency against CDK4/6 and >2,000-fold selectivity against other CDK family members (CDK1, CDK2, and CDK9). PRT3645 exhibits anti-cell proliferation in glioblastoma (GBM) cell lines and in HER2− and HER2+ breast cancer lines (EC50 of < 125 nM), and demonstrates anti-tumor activity and enhances survival in glioblastoma and breast cancer brain metastasis models.